Epigenetics and the Environment
暂无分享,去创建一个
[1] C. Davis,et al. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. , 2000, The Journal of nutrition.
[2] T. Skopek,et al. Transgenic chinese hamster V79 cell lines which exhibit variable levels of gpt mutagenesis , 1990, Environmental and molecular mutagenesis.
[3] H. Mollenhauer,et al. Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake. , 1980, Science.
[4] M. Mass,et al. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. , 2001, Toxicology letters.
[5] R. Watson,et al. Epigenetics and DNA methylation come of age in toxicology. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Paul Tempst,et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.
[7] P. Marks,et al. Histone deacetylases and cancer: causes and therapies , 2001, Nature Reviews Cancer.
[8] J. Barrett,et al. Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. , 1991, Science.
[9] A. Bird,et al. MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin , 1997, Cell.
[10] Lung-Chi Chen,et al. Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. , 2003, Toxicology and applied pharmacology.
[11] Rudolf Jaenisch,et al. DNA hypomethylation leads to elevated mutation rates , 1998, Nature.
[12] B. Tycko. Genomic imprinting and cancer. , 1999, Results and problems in cell differentiation.
[13] K. Kitchin. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. , 2001, Toxicology and applied pharmacology.
[14] J. Basilion,et al. Preferential DNA-protein cross-linking by NiCl2 in magnesium-insoluble regions of fractionated Chinese hamster ovary cell chromatin. , 1985, Cancer research.
[15] J. Arbiser,et al. Reactive Oxygen-induced Carcinogenesis Causes Hypermethylation of p16Ink4a and Activation of MAP Kinase , 2002, Molecular medicine.
[16] Luke Hughes-Davies,et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity , 2000, Nature Genetics.
[17] G. Pfeifer. p53 mutational spectra and the role of methylated CpG sequences. , 2000, Mutation research.
[18] B. Diwan,et al. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Feinberg,et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.
[20] T. Bestor,et al. Cytosine methylation and human cancer. , 2000, Current opinion in oncology.
[21] Colin A. Johnson,et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.
[22] R. Caprioli,et al. Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture. , 1981, Cancer research.
[23] C. Klein,et al. Nickel carcinogenesis, mutation, epigenetics, or selection. , 1999, Environmental health perspectives.
[24] S. Cross,et al. Gene silencing by methyl-CpG-binding proteins. , 1998, Novartis Foundation symposium.
[25] J. Strouboulis,et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.
[26] S. Patierno,et al. Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds , 1989, Environmental and molecular mutagenesis.
[27] H. Molinari,et al. Interaction of Ni(II) and Cu(II) with a metal binding sequence of histone H4: AKRHRK, a model of the H4 tail. , 2000, Biochimica et biophysica acta.
[28] B. Tycko,et al. Epigenetic gene silencing in cancer. , 2000, The Journal of clinical investigation.
[29] V. Karantza,et al. Interaction of Nickel(II) with histones: in vitro binding of nickel(II) to the core histone tetramer. , 1999, Archives of biochemistry and biophysics.
[30] M. Nishiyama,et al. Histone deacetylase as a new target for cancer chemotherapy , 2001, Cancer Chemotherapy and Pharmacology.
[31] S. Patierno,et al. DNA-protein cross-links induced by nickel compounds in intact cultured mammalian cells. , 1985, Chemico-biological interactions.
[32] C. Allis,et al. The language of covalent histone modifications , 2000, Nature.
[33] Y. W. Lee,et al. Mutagenicity of soluble and insoluble nickel compounds at the gpt locus in G12 chinese hamster cells , 1993, Environmental and molecular mutagenesis.
[34] E. Nieboer,et al. Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds. , 1994, Environmental health perspectives.
[35] Peter A. Jones,et al. DNA Methylation as a Target for Drug Design , 1998, Pharmaceutical Research.
[36] A. Feinberg. DNA methylation, genomic imprinting and cancer. , 2000, Current topics in microbiology and immunology.
[37] Hsu Tc. A possible function of constitutive heterochromatin: the bodyguard hypothesis. , 1975 .
[38] M. Costa,et al. Antagonistic effect of magnesium chloride on the nickel chloride-induced inhibition of DNA replication in Chinese hamster ovary cells. , 1986, Journal of biochemical toxicology.
[39] A. Bird,et al. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.
[40] M. Costa,et al. Pathway of nickel uptake influences its interaction with heterochromatic DNA. , 1986, Toxicology and applied pharmacology.
[41] Jie Liu,et al. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. , 2001, Toxicology and applied pharmacology.
[42] E. Ballestar,et al. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation , 1999, Nature Genetics.
[43] M. Costa,et al. Metal mutagenesis in transgenic Chinese hamster cell lines. , 1994, Environmental health perspectives.
[44] W. Wilson,et al. Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. , 2001, Blood.
[45] M. Tang,et al. Mutation hotspots and DNA methylation. , 2000, Current topics in microbiology and immunology.
[46] R. S. Yang,et al. Pharmacokinetics, metabolism, and carcinogenicity of arsenic. , 2001, Reviews of environmental contamination and toxicology.
[47] J. Herman,et al. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.
[48] N. Rushton,et al. Neoplastic transformation of cells by soluble but not particulate forms of metals used in orthopaedic implants. , 1998, Biomaterials.
[49] M. Costa,et al. Nickel enhances telomeric silencing in Saccharomyces cerevisiae. , 1999, Mutation research.
[50] M. Kuo,et al. Nickel compounds are novel inhibitors of histone H4 acetylation. , 2000, Cancer research.
[51] V. Richon,et al. Histone deacetylase inhibitors as new cancer drugs , 2001, Current opinion in oncology.
[52] Peter A. Jones,et al. The Role of DNA Methylation in Mammalian Epigenetics , 2001, Science.
[53] J. Herman,et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.
[54] W. Bal,et al. Interactions of Nickel(II) with histones: interactions of Nickel(II) with CH3CO-Thr-Glu-Ser-His-His-Lys-NH2, a peptide modeling the potential metal binding site in the "C-Tail" region of histone H2A. , 1998, Chemical research in toxicology.
[55] H. Wesch,et al. Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of BigBlue rats and Muta Mouse mice in vivo after inhalation. , 1998, Mutation research.
[56] H. Mollenhauer,et al. Phagocytosis of nickel subsulfide particles during the early stages of neoplastic transformation in tissue culture. , 1980, Cancer research.
[57] A. Bird,et al. Effects of DNA methylation on DNA-binding proteins and gene expression. , 1993, Current opinion in genetics & development.
[58] M. Tang,et al. Cytosine methylation determines hot spots of DNA damage in the human P53 gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[59] T. Richmond,et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.
[60] R Doll,et al. Cancers of the lung and nasal sinuses in nickel workers: a reassessment of the period of risk. , 1977, British journal of industrial medicine.
[61] M. Ehrlich,et al. The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.
[62] A. Wolffe,et al. Relationships between chromatin organization and DNA methylation in determining gene expression. , 1999, Seminars in cancer biology.
[63] S. Patierno,et al. Effects of nickel(II) on nuclear protein binding to DNA in intact mammalian cells. , 1987, Cancer biochemistry biophysics.
[64] A. Bird,et al. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl‐CpG binding protein. , 1992, The EMBO journal.
[65] M. Costa,et al. Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines at the xanthine-guanine phosphoribosyl transferase locus. , 1993, Mutation research.
[66] M. Costa,et al. Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells. , 1989, Cancer research.
[67] E. Pennisi. Behind the Scenes of Gene Expression , 2001, Science.
[68] R. Watson,et al. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. , 2002, Annual review of pharmacology and toxicology.
[69] S. Robison,et al. Selective phagocytosis of crystalline metal sulfide particles and DNA strand breaks as a mechanism for the induction of cellular transformation. , 1982, Cancer research.
[70] B. D. Beck,et al. The enigma of arsenic carcinogenesis: role of metabolism. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[71] M. Costa,et al. Factors influencing the phagocytosis, neoplastic transformation, and cytotoxicity of particulate nickel compounds in tissue culture systems. , 1981, Toxicology and applied pharmacology.
[72] M. Lübbert,et al. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. , 2000, Current topics in microbiology and immunology.
[73] M. Costa,et al. Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells. , 1982, Cancer research.
[74] A. Bird,et al. Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation. , 2000, Current topics in microbiology and immunology.
[75] C. Allis,et al. Translating the Histone Code , 2001, Science.
[76] M. Dizdaroglu,et al. Ni(II) specifically cleaves the C-terminal tail of the major variant of histone H2A and forms an oxidative damage-mediating complex with the cleaved-off octapeptide. , 2000, Chemical research in toxicology.
[77] Liang Wang,et al. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. , 1997, Mutation research.
[78] A. Haugen,et al. Immortalization of normal human kidney epithelial cells by nickel(II). , 1989, Cancer research.
[79] R. Jirtle,et al. Genomic imprinting and cancer. , 1999, Experimental cell research.
[80] P. Laird. Oncogenic mechanisms mediated by DNA methylation. , 1997, Molecular medicine today.
[81] S. Murphy,et al. Imprinted genes as potential genetic and epigenetic toxicologic targets. , 2000, Environmental health perspectives.
[82] M. Costa,et al. The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. , 2001, Mutation research.
[83] A. Wolffe. Packaging principle: how DNA methylation and histone acetylation control the transcriptional activity of chromatin. , 1998, The Journal of experimental zoology.
[84] Y. W. Lee,et al. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens , 1995, Molecular and cellular biology.
[85] S. Baylin,et al. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. , 1991, Cancer cells.
[86] A. Wolffe,et al. Epigenetics: regulation through repression. , 1999, Science.
[87] B. Fowler,et al. Arsenic: health effects, mechanisms of actions, and research issues. , 1999, Environmental health perspectives.